United Therapeutics Corporation has announced two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program.
Actavis has announced the planned senior management team that will lead the global...
Gilead Sciences has announced that Philippe C. Bishop, MD, will join the company as Senior Vice...
Walgreens announced that Greg Wasson, president and chief executive officer, has informed the...
The Parenteral Drug Association (PDA) announced today the results of its 2014 Board of Directors election. PDA members voted for four volunteer directors over a period of three months this past fall.
ATS Labs is changing its company name to Accuratus Lab Services. ATS Labs recently completed a large acquisition of the assets of Microtest Laboratories enabling it to expand its service offering into the growing medical device and pharmaceutical market segments.
The facility recently completed the integration of staff into the state-of-the-art manufacturing suite and product development laboratories. The U.S. Operations Center will house 275 employees across management, administration, commercial operations, manufacturing and R&D, a set up designed to allow unique opportunities for collaboration across various operational disciplines.
GlaxoSmithKline released details of a restructuring program Wednesday, which included 900 layoffs.
Spark Therapeutics has announced today appointment of Daniel M. Takefman, Ph.D., as head of regulatory affairs. Dr. Takefman previously served as chief of the gene therapy branch of the Center for Biologics Evaluation and Research at the FDA, a position he held since 2006.
Zoetis today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization.
Rigel Pharmaceuticals today announced James M. Gower is retiring from the board of directors and from his positions as chairman and chief executive officer, and Raul Rodriguez, most recently serving as the company's president and chief operating officer, will assume the position of chief executive officer and join the board of directors.
Shire has announced plans to relocate over 500 positions to Massachusetts from its Chesterbrook, Pennsylvania site and establish Lexington, Massachusetts as the company's U.S. operational headquarters. The transition is a continuation of the company's 'One Shire' efficiency program and will streamline business globally through two principal locations - Massachusetts and Switzerland.
Sanofi announced today that it has appointed Chief Scientific Officer Dr. Gary J. Nabel, M.D., Ph.D., as its Ebola response coordinator.
Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the company as Vice President of Medical Affairs.
The Department of Veterans Affairs has fired the director of the Pittsburgh VA Healthcare System a month after officials determined she committed unspecified "conduct unbecoming a senior executive" and wasteful spending.
Actavis has announced that Maria Teresa (Tessa) Hilado will join the company, effective December 8, 2014, as Chief Financial Officer. Ms. Hilado brings more than 26 years of global finance experience to the position, and will be based at the company's Parsippany, NJ, U.S. Administrative Headquarters.
Alexion Pharmaceuticals has named Senior Vice President Julie O'Neill to replace company co-founder Stephen Squinto when the executive vice president and chief global operations officer retires Jan. 1
Alfa Laval intends to consolidate the European manufacturing footprint of air heat exchangers for refrigeration applications to existing manufacturing sites in Italy, Poland and Finland. The intention is to close the site in Groningen, the Netherlands, by September 2015.
AcelRx Pharmaceuticals has announced the departure of Richard King, the company's CEO and President. The Board of Directors has initiated a CEO search and Mr. King will remain with the company as President and Chief Executive Officer while the search is ongoing and during this transition period.
Reckitt Benckiser Pharmaceuticals has announced the appointment of Cary J. Claiborne as Chief Financial Officer. Cary will lead the company's global financial and information technology operations, reporting to Chief Executive Officer Shaun Thaxter effective November 10, 2014.
Warren M. Anderson, who headed Union Carbide Corp. when a chemical leak killed thousands of people in Bhopal, India, in 1984, has died in Florida at 92. Anderson's death was not announced by his family but was confirmed Friday by The Associated Press through public records.
Impax Laboratories has announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the generic and brand businesses
The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has elected Peter Bigelow to serve as Chairman of the Board of Trustees.
Novo Nordisk has announced plans to hire up to 90 people at its newly-acquired manufacturing plant in West Lebanon, NH. The facility was formerly owned by Olympus Biotech.
The U.S. health care apparatus is so unprepared and short on resources to deal with the deadly Ebola virus that even small clusters of cases could overwhelm parts of the system, according to an Associated Press review of readiness at hospitals and other components of the emergency medical network.
Alnylam Pharmaceuticals has announced the appointment of Pushkal Garg, M.D., to the position of Senior Vice President, Clinical Development. At Alnylam, he will join the existing development team and be responsible for managing the company’s clinical research, clinical operations, and biometrics functions.
Sanofi sacked its CEO Wednesday following a board room rift over the handling of one of France's largest publicly traded companies. Christopher Viehbacher, the first non-Frenchman to lead Sanofi, was dismissed after six years running the company that traces its roots to the early 19th century.
Catalent today announced the promotion of Australia Country General Manager, Mark Bisset, to President, Catalent Asia Pacific. He succeeds David Heyens who has announced that he plans to retire from Catalent on December 31st 2014.
Amgen said Monday that its earnings fell in the third quarter on charges from an ongoing restructuring effort, but the biotech drugmaker's adjusted results still surpassed Wall Street expectations.
- Page 1